Dongxia Gao

8.6k total citations · 2 hit papers
57 papers, 5.1k citations indexed

About

Dongxia Gao is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Dongxia Gao has authored 57 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 27 papers in Cancer Research and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Dongxia Gao's work include Breast Cancer Treatment Studies (21 papers), Cancer Immunotherapy and Biomarkers (19 papers) and HER2/EGFR in Cancer Research (11 papers). Dongxia Gao is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), Cancer Immunotherapy and Biomarkers (19 papers) and HER2/EGFR in Cancer Research (11 papers). Dongxia Gao collaborates with scholars based in Canada, United States and China. Dongxia Gao's co-authors include Torsten O. Nielsen, Samuel Leung, Stephen Chia, Maggie C.U. Cheang, Matthew J. Ellis, Philip S. Bernard, Charles M. Perou, David Voduc, Sherri R. Davies and Joel S. Parker and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Dongxia Gao

53 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

2009 1.6k citations Maggie C.U. Cheang, Stephen Chia et al. JNCI Journal of the National Cancer Institute profile →
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

2015 437 citations Fanny Dupuy, Sébastien Tabariès et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Dongxia Gao

Since Specialization

Citations

This map shows the geographic impact of Dongxia Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongxia Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongxia Gao more than expected).

Fields of papers citing papers by Dongxia Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongxia Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongxia Gao. The network helps show where Dongxia Gao may publish in the future.

Co-authorship network of co-authors of Dongxia Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Dongxia Gao. A scholar is included among the top collaborators of Dongxia Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongxia Gao. Dongxia Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors and diagnostic biomarkers for asymptomatic immune checkpoint inhibitor-related myocarditis in patients with esophageal cancer after immunotherapy 2025 ·World Journal of Gastroenterology ·Jingyu Liu, Dongxia Gao, (unknown)	0
2	Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial 2022 ·Cancers ·(unknown), Elisabeth Specht Stovgaard, Maj‐Britt Jensen, Karama Asleh, Nazia Riaz, Dongxia Gao, Samuel Leung, Bent Ejlertsen, Anne‐Vibeke Lænkholm, Torsten O. Nielsen	2
3	A clinical calculator to predict disease outcomes in women with triple-negative breast cancer 2021 ·Breast Cancer Research and Treatment ·Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, Samuel Leung, Angela Cheng, Dongxia Gao, Jason P. Sinnwell, Heshan Liu, David W. Hillman, (unknown), Judith A Gilbert, Vivian Negron, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, Jodi M. Carter, Daniel W. Visscher, Torsten O. Nielsen, Matthew P. Goetz	26
4	Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas 2020 ·OncoImmunology ·Amanda R. Dancsok, Dongxia Gao, Anna F. Lee, Sonja E. Steigen, Jean‐Yves Blay, David M. Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco	125
5	Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types 2020 ·Modern Pathology ·(unknown), Samantha Burugu, Dongxia Gao, (unknown), Zuzana Kos, Samuel Leung, Basil A. Horst, Torsten O. Nielsen	21
6	Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer 2020 ·Cell Reports ·Cuige Zhu, Anna Rogers, Karama Asleh, (unknown), Dongxia Gao, Samuel Leung, Shan Li, Kiran Vij, Jian Zhu, Jason M. Held, Zhongsheng You, Torsten O. Nielsen, Jieya Shao	23
7	Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically 2019 ·Cancer Immunology Research ·Shawn C. Chafe, Paul C. McDonald, Saeed Saberi, Oksana Nemirovsky, Geetha Venkateswaran, Samantha Burugu, Dongxia Gao, Alberto Delaidelli, Alastair H. Kyle, Jennifer H.E. Baker, Jordan Gillespie, Ali Bashashati, Andrew I. Minchinton, Youwen Zhou, Sohrab P. Shah, Shoukat Dedhar	126
8	Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort 2019 ·Breast Cancer Research and Treatment ·Angela Cheng, Samuel Leung, Dongxia Gao, Samantha Burugu, Meenakshi Anurag, Matthew J. Ellis, Torsten O. Nielsen	38
9	Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas 2019 ·Modern Pathology ·Amanda R. Dancsok, Nokitaka Setsu, Dongxia Gao, Jean‐Yves Blay, David M. Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco	61
10	LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors 2017 ·Annals of Oncology ·(unknown), Dongxia Gao, Samuel Leung, Stephen Chia, Torsten O. Nielsen	146
11	Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma 2017 ·BMC Cancer ·Basile Tessier‐Cloutier, Steve E. Kalloger, Mohammad H. Alkandari, Katy Milne, Dongxia Gao, Brad H. Nelson, Daniel J. Renouf, Brandon S. Sheffield, David F. Schaeffer	33
12	High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial 2016 ·Clinical Cancer Research ·Torsten O. Nielsen, (unknown), Samantha Burugu, Dongxia Gao, (unknown), Eva Balslev, Bent Ejlertsen	41
13	Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma 2015 ·Clinical Cancer Research ·Minh Nguyen, Shuichi Miyakawa, Junichi Kato, Toshiyuki Mori, (unknown), Mark Armanini, Karen Gelmon, Rinat Yerushalmi, Samuel Leung, Dongxia Gao, Gregory M. Landes, Mary Haak‐Frendscho, (unknown), Andrew D. Simmons	19
14	PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer breakdown → 2015 ·Cell Metabolism ·Fanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, Zhifeng Dong, Julianna Blagih, Matthew G. Annis, Atilla Ömeroğlu, Dongxia Gao, Samuel Leung, Eitan Amir, Mark Clemons, Adriana Aguilar‐Mahecha, Mark Basik, Emma E. Vincent, Julie St‐Pierre, Russell G. Jones, Peter M. Siegel	437
15	Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial 2014 ·Breast Cancer Research and Treatment ·Shuzhen Liu, Judy-Anne W. Chapman, Margot J. Burnell, Mark N. Levine, Kathleen I. Pritchard, Timothy J. Whelan, Hope S. Rugo, Kathy S. Albain, Edith A. Perez, Shakeel Virk, Garrett Barry, Dongxia Gao, Patti O’Brien, Lois E. Shepherd, Torsten O. Nielsen, Karen A. Gelmon	37
16	Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens 2014 ·BMC Cancer ·Torsten O. Nielsen, Brett Wallden, Carl Schaper, Sean Ferree, Shuzhen Liu, Dongxia Gao, Garrett Barry, Naeem Dowidar, (unknown), James J. Storhoff	211
17	An International Ki67 Reproducibility Study 2013 ·JNCI Journal of the National Cancer Institute ·Mei‐Yin C. Polley, Samuel Leung, Lisa M. McShane, Dongxia Gao, Judith Hugh, Mauro G. Mastropasqua, Giuseppe Viale, Lila Zabaglo, Frédérique Penault‐Llorca, John M.S. Bartlett, Allen M. Gown, W. Fraser Symmans, Tammy Piper, Erika Mehl, Rebecca A. Enos, Daniel F. Hayes, Mitch Dowsett, Torsten O. Nielsen	429
18	Calculator for ovarian carcinoma subtype prediction 2010 ·Modern Pathology ·Steve E. Kalloger, Martin Köbel, Samuel Leung, Erika Mehl, Dongxia Gao, (unknown), Christine Chow, Blaise Clarke, David G. Huntsman, C. Blake Gilks	68
19	Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer breakdown → 2009 ·JNCI Journal of the National Cancer Institute ·Maggie C.U. Cheang, Stephen Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri R. Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen	1641
20	[Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies]. 2005 ·PubMed ·Fei Pei, Jie Zheng, Zifen Gao, Yanfeng Zhong, Weigang Fang, Encong Gong, (unknown), (unknown), Dongxia Gao, Zhigang Xie, Min Lü, Xueying Shi, (unknown), Jingping Yang, Yuping Wang, (unknown), (unknown), (unknown), Jiang Gu	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact